Skip to content
Builders in Fintech

Angle Health raises $200M Series C at $2.7B valuation led by Vitruvian Partners

Angle Health raises a $200M Series C at a $2.7B valuation led by Vitruvian Partners, alongside a $400M tender offer.

By Michele Mattei

Angle Health raises a $200M Series C at a $2.7B valuation led by Vitruvian Partners, alongside a $400M tender offer.

Angle Health has announced a $600 million equity financing at a $2.7 billion valuation: a $200 million Series C and a $400 million tender offer for existing shareholders. Vitruvian Partners led, with new investor Town Hall Ventures and existing investors Blumberg Capital, Portage Ventures, PruVen Capital and Y Combinator. The deal is expected to close later in September.

Founded in 2019 by former Palantir engineers Ty Wang (CEO) and Anirban Gangopadhyay (CTO), the San Francisco company runs an AI-native health benefits platform for small and midsize businesses, covering employers with as few as two staff. Its Benefit Builder tool lets brokers generate underwritten quotes in minutes.

Angle serves more than 5,000 employers across 47 states, reports 120% year-on-year growth and four consecutive profitable quarters, and handles nearly $1 billion in annualised premium-equivalents. The valuation has more than doubled since the $134 million Series B led by Portage in December 2025.

The read: two thirds of the round is secondary. The Wall Street Journal reports the tender priced at $2.5 billion, below the headline.

ShareXLinkedIn

Have fintech news? Submit it

Get fintech news by email

Read by 25,000+ fintech builders across LinkedIn, Substack and the media platform

Which emails?

By subscribing you agree to the privacy notice. We'll email you once to confirm.

See a recent editionAll newsletters